231 related articles for article (PubMed ID: 27826704)
1. Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease.
Wada N; Takaki A; Ikeda F; Yasunaka T; Onji M; Nouso K; Nakatsuka A; Wada J; Koike K; Miyahara K; Shiraha H; Yamamoto K; Okada H
Hepatol Int; 2017 Jan; 11(1):115-124. PubMed ID: 27826704
[TBL] [Abstract][Full Text] [Related]
2. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.
Rau M; Schilling AK; Meertens J; Hering I; Weiss J; Jurowich C; Kudlich T; Hermanns HM; Bantel H; Beyersdorf N; Geier A
J Immunol; 2016 Jan; 196(1):97-105. PubMed ID: 26621860
[TBL] [Abstract][Full Text] [Related]
3. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
[TBL] [Abstract][Full Text] [Related]
4. Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD.
du Plessis J; Korf H; van Pelt J; Windmolders P; Vander Elst I; Verrijken A; Hubens G; Van Gaal L; Cassiman D; Nevens F; Francque S; van der Merwe S
PLoS One; 2016; 11(12):e0166048. PubMed ID: 27992443
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Protein Signatures as Predictive Disease-Specific Markers for Non-Alcoholic Steatohepatitis (NASH).
Mounika N; Mungase SB; Verma S; Kaur S; Deka UJ; Ghosh TS; Adela R
Inflammation; 2024 Apr; ():. PubMed ID: 38676759
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.
Kado A; Tsutsumi T; Enooku K; Fujinaga H; Ikeuchi K; Okushin K; Moriya K; Yotsuyanagi H; Koike K
J Gastroenterol; 2019 Aug; 54(8):730-741. PubMed ID: 30830270
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of non-alcoholic steatohepatitis with arterial endothelial function and atherosclerosis].
Cao Y; Li L
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):205-8. PubMed ID: 24824123
[TBL] [Abstract][Full Text] [Related]
8. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
[TBL] [Abstract][Full Text] [Related]
9. The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.
Shimomura Y; Takaki A; Wada N; Yasunaka T; Ikeda F; Maruyama T; Tamaki N; Uchida D; Onishi H; Kuwaki K; Nakamura S; Nouso K; Miyake Y; Koike K; Tomofuji T; Morita M; Yamamoto K; Okada H
Intern Med; 2017; 56(3):243-251. PubMed ID: 28154266
[TBL] [Abstract][Full Text] [Related]
10. Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH).
Utsunomiya H; Yamamoto Y; Takeshita E; Tokumoto Y; Tada F; Miyake T; Hirooka M; Abe M; Kumagi T; Matsuura B; Ikeda Y; Hiasa Y
J Gastroenterol; 2017 Aug; 52(8):940-954. PubMed ID: 28062946
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR-4/FoxO3 pathway.
Samy AM; Kandeil MA; Sabry D; Abdel-Ghany AA; Mahmoud MO
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300631. PubMed ID: 38574101
[TBL] [Abstract][Full Text] [Related]
12. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
Imajo K; Hyogo H; Yoneda M; Honda Y; Kessoku T; Tomeno W; Ogawa Y; Taguri M; Mawatari H; Nozaki Y; Fujita K; Kirikoshi H; Saito S; Sumida Y; Ono M; Wada K; Nakajima A; Eguchi Y
PLoS One; 2014; 9(12):e115403. PubMed ID: 25541989
[TBL] [Abstract][Full Text] [Related]
13. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
Liu X; Wang Y; Ming Y; Song Y; Zhang J; Chen X; Zeng M; Mao Y
PLoS One; 2015; 10(5):e0127352. PubMed ID: 25993652
[TBL] [Abstract][Full Text] [Related]
14. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
[TBL] [Abstract][Full Text] [Related]
15. Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
Hadinia A; Doustimotlagh AH; Goodarzi HR; Arya A; Jafarinia M
Iran J Immunol; 2019 Dec; 16(4):327-333. PubMed ID: 31885010
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease.
Lefere S; Van de Velde F; Devisscher L; Bekaert M; Raevens S; Verhelst X; Van Nieuwenhove Y; Praet M; Hoorens A; Van Steenkiste C; Van Vlierberghe H; Lapauw B; Geerts A
Int J Obes (Lond); 2017 Aug; 41(8):1207-1213. PubMed ID: 28461687
[TBL] [Abstract][Full Text] [Related]
17. Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis.
Yamada K; Mizukoshi E; Seike T; Horii R; Terashima T; Iida N; Kitahara M; Sunagozaka H; Arai K; Yamashita T; Honda M; Takamura T; Harada K; Kaneko S
J Gastroenterol Hepatol; 2019 Oct; 34(10):1829-1835. PubMed ID: 30864239
[TBL] [Abstract][Full Text] [Related]
18. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
Chatterjee A; Basu A; Das K; Singh P; Mondal D; Bhattacharya B; Roychoudhury S; Majumder PP; Chowdhury A; Basu P
Ann Hepatol; 2020; 19(5):472-481. PubMed ID: 32682086
[TBL] [Abstract][Full Text] [Related]
19. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis.
Apostolopoulou M; Gordillo R; Koliaki C; Gancheva S; Jelenik T; De Filippo E; Herder C; Markgraf D; Jankowiak F; Esposito I; Schlensak M; Scherer PE; Roden M
Diabetes Care; 2018 Jun; 41(6):1235-1243. PubMed ID: 29602794
[TBL] [Abstract][Full Text] [Related]
20. [The significance of 8-hydroxy-deoxyguanosine acid in the diagnosis of nonalcoholic steatohepatitis].
Jiang Y; Han T; Zhang ZG; Lu SQ; Mi YQ; Xu L; Qi FX; Zhang Y; Song GD
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):34-38. PubMed ID: 28056321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
